Romanian pharmaceutical producer Antibiotice SA wins a tender worth €11mln in the United Kingdom, according to a report published on the Bucharest Stock Exchange.
Antibiotice Iasi won the tender held by the UK Department of Health and Social Care for a number of 5 anti-infective products for injection, which are used in the treatment of Covid-19 associated bacterial superinfections.
Antibiotice stated that the contract will run for a period of 2 years and the first deliveries will be made starting January 2022, without jeopardizing the supply of all hospitals in Romania with beta-lactam medicinal products for injection.
Entering the UK market is part of the territorial expansion strategy of Antibiotice. The company carries out different projects in Brazil, Australia and Northern-Europe countries (Finland, Sweden, Norway, Denmark).